43
Participants
Start Date
February 28, 2011
Primary Completion Date
April 30, 2014
Study Completion Date
May 31, 2014
AMG 181
Four escalating dose levels of AMG 181 administered as multiple doses of AMG 181 in healthy subjects, in subjects with active ulcerative colitis, and in subjects with active Crohn's disease.
Placebo for AMG 181
Four escalating dose levels of AMG 181 administered as multiple doses of AMG 181 in healthy subjects, in subjects with active ulcerative colitis, and in subjects with active Crohn's disease.
Research Site, Prahran
Research Site, Herston
Research Site, Adelaide
Research Site, Duncansville
Research Site, Miami
Research Site, Glendale
Research Site, Bridgeport
Research Site, Danbury
Lead Sponsor
Amgen
INDUSTRY